Nanoparticles decorated with ligands for cardiomyocyte-specific receptors enable passive targeting (e.g., the EPR effect), active targeting, and intelligent drug release in response to the pathological microenvironment (e.g., pH and enzymes), ensuring drug enrichment and localized release at the cardiac site [255, 256]
Quick Answer: Original Russian protocol: 5 to 10 mg SC daily for 10 to 20 days, 2 to 4 cycles per year Total annual exposure under these protocols ranges from roughly 100 mg (5 mg x 10 days x 2 courses) to 800 mg (10 mg x 20 days x 4 courses)
[9] For wound healing specifically, the evidence is stronger than for cosmetic anti-aging, because wound models involve measurable endpoints (wound closure rate, tissue tensile strength, histological analysis) in controlled animal studies
found that IL-1 generated during IDD further stimulated VEGF, NGF, and BDNF production and induced angiogenesis and innervation in degenerative IVDs